DENTSPLY SIRONA (NASDAQ:XRAY) Hits New 12-Month Low on Disappointing Earnings

by · The Markets Daily

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report) reached a new 52-week low on Friday following a weaker than expected earnings announcement. The company traded as low as $8.14 and last traded at $9.0430, with a volume of 901,655 shares. The stock had previously closed at $10.09.

The medical instruments supplier reported $0.29 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.31 by ($0.02). The company had revenue of $836.00 million for the quarter, compared to the consensus estimate of $861.68 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The firm’s revenue was down 7.5% compared to the same quarter last year. During the same period last year, the business posted $0.37 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS.

Key DENTSPLY SIRONA News

Here are the key news stories impacting DENTSPLY SIRONA this week:

  • Positive Sentiment: The company’s third-quarter loss narrowed, according to an earnings report. Dentsply Sirona Q3 Loss Narrows
  • Negative Sentiment: Quarterly adjusted EPS was $0.29, below the roughly $0.30–$0.31 analysts expected and down from $0.37 a year earlier. Revenue of $836 million also missed the $861.68 million consensus and declined 7.5% year over year. DENTSPLY SIRONA quarterly earnings
  • Negative Sentiment: 2026 guidance came in below analyst expectations: DENTSPLY SIRONA forecast EPS of $1.20–$1.30 versus a $1.47 consensus, and revenue of $3.5 billion versus $3.6 billion expected. The outlook reinforces concerns about soft demand and ongoing business pressures. DENTSPLY SIRONA Q3 and nine-month results

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on XRAY. Piper Sandler dropped their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research report on Friday, October 9th. Barrington Research reduced their target price on shares of DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating for the company in a report on Monday, October 26th. Leerink Partners decreased their price target on shares of DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating for the company in a research report on Wednesday, October 14th. Mizuho lowered their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Thursday, October 22nd. Finally, BMO Capital Markets reduced their price objective on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating for the company in a research note on Thursday, September 17th. Three analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $12.58.

Check Out Our Latest Research Report on XRAY

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors have recently bought and sold shares of XRAY. AlphaCore Capital LLC increased its stake in DENTSPLY SIRONA by 9.9% during the 3rd quarter. AlphaCore Capital LLC now owns 14,386 shares of the medical instruments supplier’s stock valued at $127,000 after purchasing an additional 1,298 shares in the last quarter. Private Management Group Inc. raised its holdings in shares of DENTSPLY SIRONA by 18.9% in the third quarter. Private Management Group Inc. now owns 2,936,998 shares of the medical instruments supplier’s stock worth $26,022,000 after buying an additional 466,272 shares during the last quarter. Fulcrum Asset Management LLP acquired a new stake in shares of DENTSPLY SIRONA during the third quarter worth $249,000. Brighton Jones LLC lifted its stake in shares of DENTSPLY SIRONA by 7.6% during the third quarter. Brighton Jones LLC now owns 37,673 shares of the medical instruments supplier’s stock worth $334,000 after buying an additional 2,668 shares during the period. Finally, CenterBook Partners LP grew its holdings in shares of DENTSPLY SIRONA by 46.8% during the third quarter. CenterBook Partners LP now owns 49,760 shares of the medical instruments supplier’s stock valued at $441,000 after buying an additional 15,858 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

The company has a current ratio of 1.63, a quick ratio of 1.07 and a debt-to-equity ratio of 1.48. The firm has a 50-day moving average of $9.63 and a 200-day moving average of $11.29. The stock has a market capitalization of $1.88 billion, a price-to-earnings ratio of -3.42, a P/E/G ratio of 1.37 and a beta of 0.87.

DENTSPLY SIRONA Company Profile

(Get Free Report)

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.

See Also